{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:40:39Z","timestamp":1786549239017,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background and objective:<\/jats:title>\n                    <jats:p>The global rise in the incidence of diabetes mellitus necessitates innovative management strategies to mitigate the severity of the disease. The mainstay of diabetes treatment is still insulin therapy, although there are drawbacks, such as the need to maintain ideal glycemic control while lowering the risk of hypoglycemia and user fatigue. The development, clinical usefulness, and constraints of insulin delivery systems are examined in this narrative review, with particular attention to sensor-augmented and closed-loop technologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A thorough electronic database search was conducted to obtain pertinent data on major insulin delivery devices, including sensor-augmented and closed-loop systems. We studied advancements in insulin delivery systems over time and their impact on the management of diabetes mellitus. We thoroughly examined both qualitative and quantitative data to summarize our conclusions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key content and findings:<\/jats:title>\n                    <jats:p>Closed-loop insulin delivery systems, which combine insulin pumps, advanced control algorithms, and continuous glucose monitoring, are the next step forward in the treatment of diabetes. These systems autonomously regulate blood glucose levels, reducing the need for user intervention. Closed-loop devices outperform sensor-augmented pump (SAP) treatment in reducing hypoglycemia, extending the time-in-range, and lowering self-management responsibilities. In order to provide real-time control, closed-loop systems dynamically modify insulin delivery in response to glucose variations by using algorithms powered by artificial intelligence. Because SAP therapy depends more on user input and may not be as successful in providing consistent glycemic control, this capability helps overcome its drawbacks. Further improving overall safety and efficacy, the closed-loop technique decreases blood glucose variability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The two primary developments in diabetes care are sensor-augmented and closed-loop insulin devices, which offer better glucose control and lower hypoglycemia rates compared to traditional therapies. Closed-loop insulin delivery systems seem to be a more clinically successful option for controlling diabetes mellitus than SAP therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000005307","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:01:34Z","timestamp":1784624494000},"page":"5175-5182","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["From algorithm to alarm: a narrative review on insulin delivery innovation"],"prefix":"10.1097","volume":"88","author":[{"given":"Noor Ul Ain","family":"Saleem","sequence":"first","affiliation":[{"name":"Department of Medicine, FMH College of Medicine and Dentistry, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz","family":"Arshad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shaikh Zayed Hospital, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Qadri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Saqlain Mushtaq","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishaim","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Medicine, FMH College of Medicine and Dentistry, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakeeza","family":"Shakoor","sequence":"additional","affiliation":[{"name":"Department of Medicine, Karachi Medical and Dental college, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tirath","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Trinity Medical Sciences University School of Medicine, Saint Vincent and the Grenadines, Kingstown, Saint Vincent and the Grenadines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anaya","family":"Noor","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow Medical College, Karachi, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Sardarova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Henry Ford Hospital, Detroit, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhilesh","family":"Anand","sequence":"additional","affiliation":[{"name":"Department of Medical Education, University of Texas Rio Grande Valley, Edinburg, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn K.","family":"Edmondson","sequence":"additional","affiliation":[{"name":"Clinical Medicine, American University of Antigua, St. John, Antigua and Barbuda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adekunle E.","family":"Omole","sequence":"additional","affiliation":[{"name":"School of Engineering Medicine, Texas A&M University, Houston, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"R1-20260812","first-page":"46\u201357","article-title":"The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus","volume":"4","author":"Ozougwu","year":"2013","journal-title":"Academic J"},{"key":"R2-20260812","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"R4-20260812","doi-asserted-by":"crossref","DOI":"10.1186\/s43162-021-00065-w","article-title":"Factors affecting glycemic control among Egyptian people with diabetes attending primary health care facilities in mansoura district","volume":"33","author":"Azzam","year":"2021","journal-title":"Egypt J Intern Med"},{"key":"R5-20260812","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.2337\/dc09-S310","article-title":"Target for glycemic control: concentrating on glucose","volume":"32","author":"Monnier","year":"2009","journal-title":"Diabetes Care"},{"key":"R6-20260812","first-page":"837\u201353","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"R7-20260812","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13256-022-03498-1","article-title":"Hypoglycemic unawareness: challenges, triggers, and recommendations in patients with hypoglycemic unawareness: a case report","volume":"16","author":"Sharifi","year":"2022","journal-title":"J Med Case Rep"},{"key":"R8-20260812","first-page":"267\u201382","article-title":"Identifying and meeting the challenges of insulin therapy in type 2 diabetes","volume":"7","author":"Sorli","year":"2014","journal-title":"J Multidiscip Healthc"},{"key":"R9-20260812","doi-asserted-by":"crossref","first-page":"534\u201338","DOI":"10.1016\/S1262-3636(06)72808-7","article-title":"Continuous glucose monitoring and external insulin pump: towards a subcutaneous closed loop","volume":"32","author":"Hanaire","year":"2006","journal-title":"Diabetes Metab"},{"key":"R10-20260812","doi-asserted-by":"crossref","first-page":"919942","DOI":"10.3389\/fendo.2022.919942","article-title":"Closed-loop insulin delivery systems: past, present, and future directions","volume":"13","author":"Templer","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R11-20260812","first-page":"31\u201334","article-title":"Sensor-augmented pump therapy - on the way to artificial pancreas","volume":"9","author":"Thomas","year":"2010","journal-title":"Infusys Int"},{"key":"R12-20260812","first-page":"100082","article-title":"Transparency in the reporting of Artificial Intelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R13-20260812","doi-asserted-by":"crossref","first-page":"1191\u201397","DOI":"10.2337\/dc13-2108","article-title":"Closed-loop artificial pancreas systems: engineering the algorithms","volume":"37","author":"Doyle","year":"2014","journal-title":"Diabetes Care"},{"key":"R14-20260812","doi-asserted-by":"crossref","first-page":"676\u201383","DOI":"10.1177\/1932296819899394","article-title":"Continuous glucose monitoring devices: past, present, and future focus on the history and evolution of technological innovation","volume":"15","author":"Didyuk","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"R15-20260812","doi-asserted-by":"crossref","first-page":"3\u201322","DOI":"10.1007\/s00125-022-05744-z","article-title":"Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the joint diabetes technology working group of the European association for the study of diabetes and the American diabetes association","volume":"66","author":"Sherr","year":"2023","journal-title":"Diabetologia"},{"key":"R16-20260812","first-page":"CD005103","article-title":"Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus","volume":"2010","author":"Misso","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-20260812","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13098-022-00962-2","article-title":"Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis","volume":"14","author":"Kang","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"R20-20260812","first-page":"1168\u201374","article-title":"Day-and-night hybrid closed-loop insulin delivery in adolescents with type 1 diabetes: a free-living, randomized clinical trial","volume":"39","author":"Tauschmann","year":"2016","journal-title":"Diabetes Care"},{"key":"R21-20260812","doi-asserted-by":"crossref","first-page":"1778\u201386","DOI":"10.2337\/dc24-0623","article-title":"Closed-loop insulin therapy for people with type 2 diabetes treated with an insulin pump: a 12-week multicenter, open-label randomized, controlled, crossover trial","volume":"47","author":"Borel","year":"2024","journal-title":"Diabetes Care"},{"key":"R22-20260812","doi-asserted-by":"crossref","first-page":"24\u201329","DOI":"10.4158\/EP.15.1.24","article-title":"Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients","volume":"15","author":"Bailon","year":"2009","journal-title":"Endocr Pract"},{"key":"R23-20260812","doi-asserted-by":"crossref","first-page":"2403\u201305","DOI":"10.2337\/dc11-1248","article-title":"Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase","volume":"34","author":"Bergenstal","year":"2011","journal-title":"Diabetes Care"},{"key":"R24-20260812","doi-asserted-by":"crossref","first-page":"1383\u201390","DOI":"10.1111\/jdi.14075","article-title":"Advantages of sensor-augmented insulin pump therapy for pregnant women with type\u20091 diabetes mellitus","volume":"14","author":"Imafuku","year":"2023","journal-title":"J Diabetes Investig"},{"key":"R25-20260812","doi-asserted-by":"crossref","first-page":"6\u20138","DOI":"10.1016\/S2213-8587(21)00289-8","article-title":"Opportunities and challenges in closed-loop systems in type 1 diabetes","volume":"10","author":"Wilson","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R26-20260812","doi-asserted-by":"crossref","first-page":"471\u201381","DOI":"10.1007\/s40618-021-01674-6","article-title":"Efficacy and safety of closed-loop insulin delivery versus sensor-augmented pump in the treatment of adults with type 1 diabetes: a systematic review and meta-analysis of randomized-controlled trials","volume":"45","author":"Fang","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"R27-20260812","doi-asserted-by":"crossref","first-page":"1707\u201317","DOI":"10.1056\/NEJMoa1907863","article-title":"Multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N Engl J Med"},{"key":"R28-20260812","doi-asserted-by":"crossref","first-page":"209\u201319","DOI":"10.1056\/NEJMoa2111673","article-title":"Randomized trial of closed-loop control in very young children with type 1 diabetes","volume":"386","author":"Ware","year":"2022","journal-title":"N Engl J Med"},{"key":"R29-20260812","doi-asserted-by":"crossref","first-page":"547\u201356","DOI":"10.1056\/NEJMoa1805233","article-title":"Closed-loop insulin delivery for glycemic control in noncritical care","volume":"379","author":"Bally","year":"2018","journal-title":"N Engl J Med"},{"key":"R30-20260812","doi-asserted-by":"crossref","first-page":"991\u20131001","DOI":"10.1056\/NEJMoa2210834","article-title":"Trial of hybrid closed-loop control in young children with type 1 diabetes","volume":"388","author":"Wadwa","year":"2023","journal-title":"N Engl J Med"},{"key":"R31-20260812","doi-asserted-by":"crossref","first-page":"1321\u201329","DOI":"10.1016\/S0140-6736(18)31947-0","article-title":"APCam11 consortium. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial","volume":"392","author":"Tauschmann","year":"2018","journal-title":"Lancet"},{"key":"R33-20260812","doi-asserted-by":"crossref","first-page":"e310523217505","DOI":"10.2174\/1573399820666230531161858","article-title":"Comparison of the sensor-augmented pump system with the advanced hybrid closed-loop delivery system: quality of life, diabetes distress, and glycaemic outcomes in a real-life context","volume":"20","author":"Benioudakis","year":"2024","journal-title":"Curr Diabetes Rev"},{"key":"R34-20260812","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.90.EP226","article-title":"Impact of hybrid closed-loop systems on diabetes management compared to sensor-assisted pump systems","author":"Ntikoudi","year":"2023","journal-title":"Endocr Abstr"},{"key":"R35-20260812","doi-asserted-by":"crossref","first-page":"1214975","DOI":"10.3389\/fendo.2023.1214975","article-title":"User experiences during the transition to calibration-free sensors with remote monitoring while using automated insulin delivery - a qualitative study","volume":"14","author":"Sehgal","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R36-20260812","doi-asserted-by":"crossref","first-page":"e230132","DOI":"10.1530\/EC-23-0132","article-title":"The changing landscape of automated insulin delivery in the management of type 1 diabetes","volume":"12","author":"Lakshman","year":"2023","journal-title":"Endocr Connect"},{"key":"R37-20260812","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41746-023-00783-1","article-title":"Enabling fully automated insulin delivery through meal detection and size estimation using Artificial Intelligence","volume":"6","author":"Mosquera-lopez","year":"2023","journal-title":"NPJ Digit Med"},{"key":"R38-20260812","doi-asserted-by":"crossref","first-page":"275\u201381","DOI":"10.1007\/s11892-022-01470-3","article-title":"The use of diabetes technology to address inequity in health outcomes: limitations and opportunities","volume":"22","author":"Agarwal","year":"2022","journal-title":"Curr Diab Rep"},{"key":"R39-20260812","doi-asserted-by":"crossref","first-page":"514\u201325","DOI":"10.1089\/dia.2023.0578","article-title":"Real-world evidence of omnipod\u00ae 5 automated insulin delivery system use in 69,902 people with type 1 diabetes","volume":"26","author":"Forlenza","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"R40-20260812","first-page":"4090\u201395","article-title":"Animal models for surgeries and implants: a vital tool in medical research and development","volume":"87","author":"Choudhary","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"R41-20260812","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1089\/dia.2023.2511","article-title":"Real-world diabetes technology: overcoming barriers and disparities","volume":"25","author":"Messer","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"R42-20260812","article-title":"1215-P: attitudes towards diabetes technology in older adults with diabetes","volume":"72","author":"Alison","journal-title":"Diabetes"},{"key":"R43-20260812","doi-asserted-by":"crossref","first-page":"6646582","DOI":"10.1155\/2023\/6646582","article-title":"Disparities in glycemic outcomes persist in youth with type 1 diabetes and high-technology use","volume":"2023","author":"Nath","year":"2023","journal-title":"Pediatr Diabetes"},{"key":"R44-20260812","doi-asserted-by":"crossref","first-page":"e005067","DOI":"10.1136\/bmjdrc-2025-005067","article-title":"Disparities in diabetes technology utilization in youth with diabetes","volume":"13","author":"Singh","year":"2025","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R45-20260812","first-page":"306\u201313","article-title":"Racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes","volume":"23","author":"Agarwal","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"R46-20260812","doi-asserted-by":"crossref","first-page":"916\u201324","DOI":"10.1177\/19322968231155150","article-title":"Telementoring with project ECHO: a new era in diabetes-related continuing education for primary care to address health disparities","volume":"17","author":"Ehrhardt","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"R47-20260812","doi-asserted-by":"crossref","first-page":"1077\u201384","DOI":"10.1177\/19322968221088327","article-title":"Strengths and challenges of closed-loop insulin delivery during exercise in people with type 1 diabetes: potential future directions","volume":"17","author":"Paldus","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"R48-20260812","article-title":"Animal Anatomical Teaching Models for Enhanced Veterinary Anatomy Education and Learning","author":"Choudhary","year":"2025","journal-title":"Pakistan Vet J"},{"key":"R49-20260812","doi-asserted-by":"crossref","first-page":"1198\u2013202","DOI":"10.4067\/S0717-95022023000401198","article-title":"ChatGPT for veterinary anatomy education: an overview of the prospects and drawbacks","volume":"41","author":"Choudhary","year":"2023","journal-title":"Int J Morphol"},{"key":"R50-20260812","doi-asserted-by":"crossref","first-page":"152366","DOI":"10.1016\/j.aanat.2024.152366","article-title":"Exploring the potential and limitations of artificial intelligence in animal anatomy","volume":"258","author":"Choudhary","year":"2025","journal-title":"Ann Anat"},{"key":"R51-20260812","first-page":"339\u201354","article-title":"Barriers to uptake of insulin technologies and novel solutions","volume":"14","author":"Pauley","year":"2021","journal-title":"Med Devices (Auckl)"},{"key":"R52-20260812","first-page":"3668","article-title":"Current concerns and future directions of large language model ChatGPT in medicine: a machine-learning-driven global-scale bibliometric analysis","volume":"161","author":"Zhang","year":"2024","journal-title":"J Surg"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000005307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:39:40Z","timestamp":1786545580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000005307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000005307","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"2025-05-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}